Article
Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg.
Vaccine - 14 Jun 2001
Heijtink R A, van Bergen P, van Roosmalen M H, Sünnen C M, Paulij W P, Schalm S W, Osterhaus A D
Abstract excerpt
The G145R mutant of the small S-protein is a major escape mutant of hepatitis B virus observed in natural infection, after immunization and HBIG therapy. In a previous study we found that plasma-derived and recombinant DNA-derived vaccine HBsAg reacted differently with monoclonal antibodies sensitive for the G145R change. In the present study we investigated the binding of polyclonal anti-HBs obtained after...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
